市場調査レポート

商品コード

ライソゾーム病治療の世界市場規模、シェア、産業動向分析レポート：疾患タイプ別、治療タイプ別、エンドユーザー別、地域別展望と予測、2022年～2028年

Global Lysosomal Disease Treatment Market Size, Share & Industry Trends Analysis Report By Disease Type, By Type of Therapy By End User, By Regional Outlook and Forecast, 2022 - 2028

出版日: 2022年08月31日 | 発行: KBV Research

| ページ情報: 英文 230 Pages | 納期: 即納可能

価格

PDF (Single User License)

USD 3,600 565,704円

レポートPDFを1名のみがご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。PDFの印刷も可能です。印刷したもののご利用はPDFのライセンス保持者に限定されます。

PDF (Site License)

USD 4,320 678,844円

レポートPDFを同一企業内の5名までご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。PDFの印刷も可能です。印刷したもののご利用はPDFのご利用範囲に準拠します。

PDF (Enterprisewide License)

USD 6,048 950,382円

レポートPDFを同一企業のすべての方に使用頂けるライセンスです。PDF内のテキスト等のコピーは可能です。PDFの印刷回数に制限はありません。印刷したもののご利用はPDFのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=157.14円

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

ライソゾーム病治療の世界市場規模は、予測期間中にCAGR6.3%の市場成長率で上昇し、2028年には110億米ドルに達すると予測されます。

細胞の高分子の分解に関与するリソソームヒドロラーゼの変異は、LSDの主な原因であり、症例の3分の2以上を占めます。その結果、LSDの貯蔵産物の中には、脂質、グリコーゲン、ムコ多糖類、糖タンパク質など、生化学的な起源を持つ様々な種類のものが存在します。LSDは、X連鎖性のファブリー病、ダノン病、ハンター病を除き、すべて常染色体劣性遺伝をします。

LSDは、単独で、あるいは多系統の疾患の一部として、大部分の臓器に影響を与え、臨床的には非常に異質です。リソソーム酵素はハウスキーピング遺伝子であり、大多数の細胞で発現しているにもかかわらず、それらが作用する組織の分布は均一ではなく、このことが、どの個体のどの組織が影響を受けるかを決定しています。

COVID-19影響度分析

COVID-19の公衆衛生危機は、ほとんどすべての産業に影響を及ぼしています。COVID-19の発生は、コロナウイルス危機が世界中を席巻し、医療従事者がその資金の大部分をCOVID-19との戦いに割かざるを得ないため、いくつかの分野、特に健康・医薬品分野にわたってライソゾーム病治療薬の市場規模に対する需要を大幅に減少させる原因となったのです。ライソゾーム貯蔵障害の患者が病院で遭遇する治療の遅れの主な要因は、感染のリスクでした。COVID-19の発生は、ライソゾーム病治療薬の世界市場の開拓を遅らせるため、2022年以降の市場価値を損ないます。

市場成長要因

ライソゾーム病の罹患率は上昇中

酵素補充療法市場の1次的な原動力は、ライソゾーム病の診断と治療のための薬剤開発のための研究開発の拡大です。ライソゾーム病の罹患率が上昇していることは、市場の成長率を加速させる重要な要因となるでしょう。National Center for Biotechnology Informationが発表したレポートによると、白人男性のコミュニティにおけるファブリー病の有病率は、2020年1月に1：17,000から1：117,000の範囲であることが示されています。非典型的な症状は、女性では約1：6000～1：40,000、男性では約1：1000～1：3000に関連し、一方、男性では1：22,000～1：40,000が古典的ファブリー病変異を有するとされています。

研究開発費を回収するための希少薬開発への金銭的インセンティブ

ライソゾーム病治療薬の市場成長率に影響を与える重要な要素として、医療費の増加（インフラの整備に貢献）が挙げられます。市場の力学は、資金を増強してヘルスケア・インフラを強化しようとするさまざまな政府組織の取り組みによって、さらに影響を受けるでしょう。さらに、ライソゾーム病治療薬の市場は、早期診断の受け入れ率の上昇と、意識を高めるための政府プログラムの増加によって成長すると思われます。これに伴い、政府の善意あるプログラムの拡大や可処分所得の増加により、市場の拡大が加速されるでしょう。

市場抑制要因

幹細胞治療には問題が多い

移植後すぐに発生する問題の多くは、直前に薬物や放射線によって骨髄が破壊されることに起因します。中には、コンディショニングの手順そのものが意図しない結果をもたらす場合もあります。患者さんは、副作用を管理するために移植チームからサポートを受けることができます。ほとんどの場合、患者さんの気分が良くなるように対処することができ、いくつかは予防することができます。これは包括的なリストではないので、経験した問題や調整について医師または移植チームにお知らせくださいです。

疾患タイプ別の見通し

ライソゾーム病治療薬市場は、疾患タイプに基づき、ゴーシェ病、ファブリー病、ポンペ症候群、ムコ多糖症、その他に区分されます。2021年のライソゾーム病治療市場において、ゴーシェ病セグメントは最も高い収益シェアを獲得しました。これは、ゴーシェ病の有病率の上昇が主な市場促進要因であるためです。さらに、このセグメントの成長は、強力な承認済み医薬品と開発中の新しい治療法によって促進されます。

治療法の種類別の展望

ライソゾーム病治療市場は、治療の種類によって、酵素補充療法、幹細胞療法、基質削減療法、その他に分けられます。幹細胞療法分野は、2021年のライソゾーム病治療市場において、かなりの収益シェアを記録しています。LSDは、リソソームヒドロラーゼの分泌-再取り込みによる交差補正を行う能力があるため、幹細胞治療のターゲットとして非常に魅力的であり、骨髄の同種移植はLSDに適用された最初の特定の治療方法でした。

エンドユーザーの展望

ライソゾーム病治療薬市場は、エンドユーザーごとに病院、診療所、その他に分類されます。ライソゾーム病のために病院での治療を希望する人の増加により、病院セグメントは2021年のライソゾーム病治療市場において最も高い売上シェアを獲得しました。臨床業務を費用対効果の高い形で効率化したいという要求の高まりに応え、病院はこれらの技術を利用しています。病院とは、熟練した医療スタッフ、事務スタッフ、医療機器などを備え、人々が医療を受けることができる施設です。

地域別の展望

ライソゾーム病治療市場は、地域別に見ると、北米、欧州、アジア太平洋、LAMEAで分析されています。北米セグメントは、2021年のライソゾーム病治療市場において最大の収益シェアを獲得しました。北米におけるライソゾーム病の高い有病率に起因します。新しい医療療法の開発、診断技術の進歩、ライソゾーム病に対する国民の意識の高まりが、この市場の拡大に拍車をかけています。各国は、この高コストという特殊な問題に対処するために、それぞれのニーズにマッチしたさまざまな戦略を用いてきました。

市場の定義
目的
市場規模
セグメンテーション
- ライソゾーム病治療の世界市場、疾患タイプ別
- ライソゾーム病治療の世界市場、治療タイプ別
- ライソゾーム病治療の世界市場、エンドユーザー別
- ライソゾーム病治療の世界市場、地域別
調査手法

第2章市場概要

イントロダクション
- 概要説明
  - 市場の構成とシナリオ
市場に影響を与える主要因
- 市場促進要因
- 市場の抑制要因

第3章ライソゾーム病治療の世界市場：疾患タイプ別

ゴーシェ病の世界市場：地域別
ファブリー病の世界市場：地域別
ムコ多糖症の世界市場：地域別
ポンペ症候群の世界市場：地域別
地域別世界のその他市場

第4章ライソゾーム病治療の世界市場：治療法タイプ別

酵素補充療法の世界市場：地域別
基質低減療法の世界市場：地域別
幹細胞療法の世界市場：地域別
世界の地域別その他市場

第5章ライソゾーム病治療の世界市場：エンドユーザー別

世界の病院市場：地域別
世界の診療所市場：地域別
世界のその他地域別市場

第6章ライソゾーム病治療薬の世界市場：地域別

北米
- 北米のライソゾーム病治療薬市場：国別
  - 米国
  - カナダ
  - メキシコ
  - 北米の残りの地域
欧州
- 欧州のライソゾーム病治療薬市場：国別
  - ドイツ
  - 英国
  - フランス
  - ロシア
  - スペイン
  - イタリア
  - その他欧州
アジア太平洋地域
- アジア太平洋地域のライソゾーム病治療薬市場：国別
  - 中国
  - 日本
  - インド
  - 韓国
  - シンガポール
  - マレーシア
  - その他アジア太平洋地域
LAMEA
- LAMEAのライソゾーム病治療薬市場：国別
  - ブラジル
  - アルゼンチン
  - UAE
  - サウジアラビア
  - 南アフリカ共和国
  - ナイジェリア
  - その他のLAMEA

第7章企業プロファイル

Merck & Co., Inc.
Johnson & Johnson（Janssen Global Services, LLC）
Eli Lilly And Company
Pfizer, Inc.
Takeda Pharmaceutical Company Limited
Sanofi S.A.
Novartis AG
AstraZeneca PLC（Alexion Pharmaceuticals, Inc.）
BioMarin Pharmaceutical Inc.
Sigilon Therapeutics, Inc.

図表

LIST OF TABLES

TABLE 1 Global Lysosomal Disease Treatment Market, 2018 - 2021, USD Million
TABLE 2 Global Lysosomal Disease Treatment Market, 2022 - 2028, USD Million
TABLE 3 Global Lysosomal Disease Treatment Market by Disease Type, 2018 - 2021, USD Million
TABLE 4 Global Lysosomal Disease Treatment Market by Disease Type, 2022 - 2028, USD Million
TABLE 5 Global Gaucher's Diseases Market by Region, 2018 - 2021, USD Million
TABLE 6 Global Gaucher's Diseases Market by Region, 2022 - 2028, USD Million
TABLE 7 Global Fabry Diseases Market by Region, 2018 - 2021, USD Million
TABLE 8 Global Fabry Diseases Market by Region, 2022 - 2028, USD Million
TABLE 9 Global Mucopolysaccharidosis Market by Region, 2018 - 2021, USD Million
TABLE 10 Global Mucopolysaccharidosis Market by Region, 2022 - 2028, USD Million
TABLE 11 Global Pompe's Syndrome Market by Region, 2018 - 2021, USD Million
TABLE 12 Global Pompe's Syndrome Market by Region, 2022 - 2028, USD Million
TABLE 13 Global Others Market by Region, 2018 - 2021, USD Million
TABLE 14 Global Others Market by Region, 2022 - 2028, USD Million
TABLE 15 Global Lysosomal Disease Treatment Market by Type of Therapy, 2018 - 2021, USD Million
TABLE 16 Global Lysosomal Disease Treatment Market by Type of Therapy, 2022 - 2028, USD Million
TABLE 17 Global Enzyme Replacement Therapy Market by Region, 2018 - 2021, USD Million
TABLE 18 Global Enzyme Replacement Therapy Market by Region, 2022 - 2028, USD Million
TABLE 19 Global Substrate Reduction Therapy Market by Region, 2018 - 2021, USD Million
TABLE 20 Global Substrate Reduction Therapy Market by Region, 2022 - 2028, USD Million
TABLE 21 Global Stem Cell Therapy Market by Region, 2018 - 2021, USD Million
TABLE 22 Global Stem Cell Therapy Market by Region, 2022 - 2028, USD Million
TABLE 23 Global Others Market by Region, 2018 - 2021, USD Million
TABLE 24 Global Others Market by Region, 2022 - 2028, USD Million
TABLE 25 Global Lysosomal Disease Treatment Market by End User, 2018 - 2021, USD Million
TABLE 26 Global Lysosomal Disease Treatment Market by End User, 2022 - 2028, USD Million
TABLE 27 Global Hospitals Market by Region, 2018 - 2021, USD Million
TABLE 28 Global Hospitals Market by Region, 2022 - 2028, USD Million
TABLE 29 Global Clinics Market by Region, 2018 - 2021, USD Million
TABLE 30 Global Clinics Market by Region, 2022 - 2028, USD Million
TABLE 31 Global Others Market by Region, 2018 - 2021, USD Million
TABLE 32 Global Others Market by Region, 2022 - 2028, USD Million
TABLE 33 Global Lysosomal Disease Treatment Market by Region, 2018 - 2021, USD Million
TABLE 34 Global Lysosomal Disease Treatment Market by Region, 2022 - 2028, USD Million
TABLE 35 North America Lysosomal Disease Treatment Market, 2018 - 2021, USD Million
TABLE 36 North America Lysosomal Disease Treatment Market, 2022 - 2028, USD Million
TABLE 37 North America Lysosomal Disease Treatment Market by Disease Type, 2018 - 2021, USD Million
TABLE 38 North America Lysosomal Disease Treatment Market by Disease Type, 2022 - 2028, USD Million
TABLE 39 North America Gaucher's Diseases Market by Country, 2018 - 2021, USD Million
TABLE 40 North America Gaucher's Diseases Market by Country, 2022 - 2028, USD Million
TABLE 41 North America Fabry Diseases Market by Country, 2018 - 2021, USD Million
TABLE 42 North America Fabry Diseases Market by Country, 2022 - 2028, USD Million
TABLE 43 North America Mucopolysaccharidosis Market by Country, 2018 - 2021, USD Million
TABLE 44 North America Mucopolysaccharidosis Market by Country, 2022 - 2028, USD Million
TABLE 45 North America Pompe's Syndrome Market by Country, 2018 - 2021, USD Million
TABLE 46 North America Pompe's Syndrome Market by Country, 2022 - 2028, USD Million
TABLE 47 North America Others Market by Country, 2018 - 2021, USD Million
TABLE 48 North America Others Market by Country, 2022 - 2028, USD Million
TABLE 49 North America Lysosomal Disease Treatment Market by Type of Therapy, 2018 - 2021, USD Million
TABLE 50 North America Lysosomal Disease Treatment Market by Type of Therapy, 2022 - 2028, USD Million
TABLE 51 North America Enzyme Replacement Therapy Market by Country, 2018 - 2021, USD Million
TABLE 52 North America Enzyme Replacement Therapy Market by Country, 2022 - 2028, USD Million
TABLE 53 North America Substrate Reduction Therapy Market by Country, 2018 - 2021, USD Million
TABLE 54 North America Substrate Reduction Therapy Market by Country, 2022 - 2028, USD Million
TABLE 55 North America Stem Cell Therapy Market by Country, 2018 - 2021, USD Million
TABLE 56 North America Stem Cell Therapy Market by Country, 2022 - 2028, USD Million
TABLE 57 North America Others Market by Country, 2018 - 2021, USD Million
TABLE 58 North America Others Market by Country, 2022 - 2028, USD Million
TABLE 59 North America Lysosomal Disease Treatment Market by End User, 2018 - 2021, USD Million
TABLE 60 North America Lysosomal Disease Treatment Market by End User, 2022 - 2028, USD Million
TABLE 61 North America Hospitals Market by Country, 2018 - 2021, USD Million
TABLE 62 North America Hospitals Market by Country, 2022 - 2028, USD Million
TABLE 63 North America Clinics Market by Country, 2018 - 2021, USD Million
TABLE 64 North America Clinics Market by Country, 2022 - 2028, USD Million
TABLE 65 North America Others Market by Country, 2018 - 2021, USD Million
TABLE 66 North America Others Market by Country, 2022 - 2028, USD Million
TABLE 67 North America Lysosomal Disease Treatment Market by Country, 2018 - 2021, USD Million
TABLE 68 North America Lysosomal Disease Treatment Market by Country, 2022 - 2028, USD Million
TABLE 69 US Lysosomal Disease Treatment Market, 2018 - 2021, USD Million
TABLE 70 US Lysosomal Disease Treatment Market, 2022 - 2028, USD Million
TABLE 71 US Lysosomal Disease Treatment Market by Disease Type, 2018 - 2021, USD Million
TABLE 72 US Lysosomal Disease Treatment Market by Disease Type, 2022 - 2028, USD Million
TABLE 73 US Lysosomal Disease Treatment Market by Type of Therapy, 2018 - 2021, USD Million
TABLE 74 US Lysosomal Disease Treatment Market by Type of Therapy, 2022 - 2028, USD Million
TABLE 75 US Lysosomal Disease Treatment Market by End User, 2018 - 2021, USD Million
TABLE 76 US Lysosomal Disease Treatment Market by End User, 2022 - 2028, USD Million
TABLE 77 Canada Lysosomal Disease Treatment Market, 2018 - 2021, USD Million
TABLE 78 Canada Lysosomal Disease Treatment Market, 2022 - 2028, USD Million
TABLE 79 Canada Lysosomal Disease Treatment Market by Disease Type, 2018 - 2021, USD Million
TABLE 80 Canada Lysosomal Disease Treatment Market by Disease Type, 2022 - 2028, USD Million
TABLE 81 Canada Lysosomal Disease Treatment Market by Type of Therapy, 2018 - 2021, USD Million
TABLE 82 Canada Lysosomal Disease Treatment Market by Type of Therapy, 2022 - 2028, USD Million
TABLE 83 Canada Lysosomal Disease Treatment Market by End User, 2018 - 2021, USD Million
TABLE 84 Canada Lysosomal Disease Treatment Market by End User, 2022 - 2028, USD Million
TABLE 85 Mexico Lysosomal Disease Treatment Market, 2018 - 2021, USD Million
TABLE 86 Mexico Lysosomal Disease Treatment Market, 2022 - 2028, USD Million
TABLE 87 Mexico Lysosomal Disease Treatment Market by Disease Type, 2018 - 2021, USD Million
TABLE 88 Mexico Lysosomal Disease Treatment Market by Disease Type, 2022 - 2028, USD Million
TABLE 89 Mexico Lysosomal Disease Treatment Market by Type of Therapy, 2018 - 2021, USD Million
TABLE 90 Mexico Lysosomal Disease Treatment Market by Type of Therapy, 2022 - 2028, USD Million
TABLE 91 Mexico Lysosomal Disease Treatment Market by End User, 2018 - 2021, USD Million
TABLE 92 Mexico Lysosomal Disease Treatment Market by End User, 2022 - 2028, USD Million
TABLE 93 Rest of North America Lysosomal Disease Treatment Market, 2018 - 2021, USD Million
TABLE 94 Rest of North America Lysosomal Disease Treatment Market, 2022 - 2028, USD Million
TABLE 95 Rest of North America Lysosomal Disease Treatment Market by Disease Type, 2018 - 2021, USD Million
TABLE 96 Rest of North America Lysosomal Disease Treatment Market by Disease Type, 2022 - 2028, USD Million
TABLE 97 Rest of North America Lysosomal Disease Treatment Market by Type of Therapy, 2018 - 2021, USD Million
TABLE 98 Rest of North America Lysosomal Disease Treatment Market by Type of Therapy, 2022 - 2028, USD Million
TABLE 99 Rest of North America Lysosomal Disease Treatment Market by End User, 2018 - 2021, USD Million
TABLE 100 Rest of North America Lysosomal Disease Treatment Market by End User, 2022 - 2028, USD Million
TABLE 101 Europe Lysosomal Disease Treatment Market, 2018 - 2021, USD Million
TABLE 102 Europe Lysosomal Disease Treatment Market, 2022 - 2028, USD Million
TABLE 103 Europe Lysosomal Disease Treatment Market by Disease Type, 2018 - 2021, USD Million
TABLE 104 Europe Lysosomal Disease Treatment Market by Disease Type, 2022 - 2028, USD Million
TABLE 105 Europe Gaucher's Diseases Market by Country, 2018 - 2021, USD Million
TABLE 106 Europe Gaucher's Diseases Market by Country, 2022 - 2028, USD Million
TABLE 107 Europe Fabry Diseases Market by Country, 2018 - 2021, USD Million
TABLE 108 Europe Fabry Diseases Market by Country, 2022 - 2028, USD Million
TABLE 109 Europe Mucopolysaccharidosis Market by Country, 2018 - 2021, USD Million
TABLE 110 Europe Mucopolysaccharidosis Market by Country, 2022 - 2028, USD Million
TABLE 111 Europe Pompe's Syndrome Market by Country, 2018 - 2021, USD Million
TABLE 112 Europe Pompe's Syndrome Market by Country, 2022 - 2028, USD Million
TABLE 113 Europe Others Market by Country, 2018 - 2021, USD Million
TABLE 114 Europe Others Market by Country, 2022 - 2028, USD Million
TABLE 115 Europe Lysosomal Disease Treatment Market by Type of Therapy, 2018 - 2021, USD Million
TABLE 116 Europe Lysosomal Disease Treatment Market by Type of Therapy, 2022 - 2028, USD Million
TABLE 117 Europe Enzyme Replacement Therapy Market by Country, 2018 - 2021, USD Million
TABLE 118 Europe Enzyme Replacement Therapy Market by Country, 2022 - 2028, USD Million
TABLE 119 Europe Substrate Reduction Therapy Market by Country, 2018 - 2021, USD Million
TABLE 120 Europe Substrate Reduction Therapy Market by Country, 2022 - 2028, USD Million
TABLE 121 Europe Stem Cell Therapy Market by Country, 2018 - 2021, USD Million
TABLE 122 Europe Stem Cell Therapy Market by Country, 2022 - 2028, USD Million
TABLE 123 Europe Others Market by Country, 2018 - 2021, USD Million
TABLE 124 Europe Others Market by Country, 2022 - 2028, USD Million
TABLE 125 Europe Lysosomal Disease Treatment Market by End User, 2018 - 2021, USD Million
TABLE 126 Europe Lysosomal Disease Treatment Market by End User, 2022 - 2028, USD Million
TABLE 127 Europe Hospitals Market by Country, 2018 - 2021, USD Million
TABLE 128 Europe Hospitals Market by Country, 2022 - 2028, USD Million
TABLE 129 Europe Clinics Market by Country, 2018 - 2021, USD Million
TABLE 130 Europe Clinics Market by Country, 2022 - 2028, USD Million
TABLE 131 Europe Others Market by Country, 2018 - 2021, USD Million
TABLE 132 Europe Others Market by Country, 2022 - 2028, USD Million
TABLE 133 Europe Lysosomal Disease Treatment Market by Country, 2018 - 2021, USD Million
TABLE 134 Europe Lysosomal Disease Treatment Market by Country, 2022 - 2028, USD Million
TABLE 135 Germany Lysosomal Disease Treatment Market, 2018 - 2021, USD Million
TABLE 136 Germany Lysosomal Disease Treatment Market, 2022 - 2028, USD Million
TABLE 137 Germany Lysosomal Disease Treatment Market by Disease Type, 2018 - 2021, USD Million
TABLE 138 Germany Lysosomal Disease Treatment Market by Disease Type, 2022 - 2028, USD Million
TABLE 139 Germany Lysosomal Disease Treatment Market by Type of Therapy, 2018 - 2021, USD Million
TABLE 140 Germany Lysosomal Disease Treatment Market by Type of Therapy, 2022 - 2028, USD Million
TABLE 141 Germany Lysosomal Disease Treatment Market by End User, 2018 - 2021, USD Million
TABLE 142 Germany Lysosomal Disease Treatment Market by End User, 2022 - 2028, USD Million
TABLE 143 UK Lysosomal Disease Treatment Market, 2018 - 2021, USD Million
TABLE 144 UK Lysosomal Disease Treatment Market, 2022 - 2028, USD Million
TABLE 145 UK Lysosomal Disease Treatment Market by Disease Type, 2018 - 2021, USD Million
TABLE 146 UK Lysosomal Disease Treatment Market by Disease Type, 2022 - 2028, USD Million
TABLE 147 UK Lysosomal Disease Treatment Market by Type of Therapy, 2018 - 2021, USD Million
TABLE 148 UK Lysosomal Disease Treatment Market by Type of Therapy, 2022 - 2028, USD Million
TABLE 149 UK Lysosomal Disease Treatment Market by End User, 2018 - 2021, USD Million
TABLE 150 UK Lysosomal Disease Treatment Market by End User, 2022 - 2028, USD Million
TABLE 151 France Lysosomal Disease Treatment Market, 2018 - 2021, USD Million
TABLE 152 France Lysosomal Disease Treatment Market, 2022 - 2028, USD Million
TABLE 153 France Lysosomal Disease Treatment Market by Disease Type, 2018 - 2021, USD Million
TABLE 154 France Lysosomal Disease Treatment Market by Disease Type, 2022 - 2028, USD Million
TABLE 155 France Lysosomal Disease Treatment Market by Type of Therapy, 2018 - 2021, USD Million
TABLE 156 France Lysosomal Disease Treatment Market by Type of Therapy, 2022 - 2028, USD Million
TABLE 157 France Lysosomal Disease Treatment Market by End User, 2018 - 2021, USD Million
TABLE 158 France Lysosomal Disease Treatment Market by End User, 2022 - 2028, USD Million
TABLE 159 Russia Lysosomal Disease Treatment Market, 2018 - 2021, USD Million
TABLE 160 Russia Lysosomal Disease Treatment Market, 2022 - 2028, USD Million
TABLE 161 Russia Lysosomal Disease Treatment Market by Disease Type, 2018 - 2021, USD Million
TABLE 162 Russia Lysosomal Disease Treatment Market by Disease Type, 2022 - 2028, USD Million
TABLE 163 Russia Lysosomal Disease Treatment Market by Type of Therapy, 2018 - 2021, USD Million
TABLE 164 Russia Lysosomal Disease Treatment Market by Type of Therapy, 2022 - 2028, USD Million
TABLE 165 Russia Lysosomal Disease Treatment Market by End User, 2018 - 2021, USD Million
TABLE 166 Russia Lysosomal Disease Treatment Market by End User, 2022 - 2028, USD Million
TABLE 167 Spain Lysosomal Disease Treatment Market, 2018 - 2021, USD Million
TABLE 168 Spain Lysosomal Disease Treatment Market, 2022 - 2028, USD Million
TABLE 169 Spain Lysosomal Disease Treatment Market by Disease Type, 2018 - 2021, USD Million
TABLE 170 Spain Lysosomal Disease Treatment Market by Disease Type, 2022 - 2028, USD Million
TABLE 171 Spain Lysosomal Disease Treatment Market by Type of Therapy, 2018 - 2021, USD Million
TABLE 172 Spain Lysosomal Disease Treatment Market by Type of Therapy, 2022 - 2028, USD Million
TABLE 173 Spain Lysosomal Disease Treatment Market by End User, 2018 - 2021, USD Million
TABLE 174 Spain Lysosomal Disease Treatment Market by End User, 2022 - 2028, USD Million
TABLE 175 Italy Lysosomal Disease Treatment Market, 2018 - 2021, USD Million
TABLE 176 Italy Lysosomal Disease Treatment Market, 2022 - 2028, USD Million
TABLE 177 Italy Lysosomal Disease Treatment Market by Disease Type, 2018 - 2021, USD Million
TABLE 178 Italy Lysosomal Disease Treatment Market by Disease Type, 2022 - 2028, USD Million
TABLE 179 Italy Lysosomal Disease Treatment Market by Type of Therapy, 2018 - 2021, USD Million
TABLE 180 Italy Lysosomal Disease Treatment Market by Type of Therapy, 2022 - 2028, USD Million
TABLE 181 Italy Lysosomal Disease Treatment Market by End User, 2018 - 2021, USD Million
TABLE 182 Italy Lysosomal Disease Treatment Market by End User, 2022 - 2028, USD Million
TABLE 183 Rest of Europe Lysosomal Disease Treatment Market, 2018 - 2021, USD Million
TABLE 184 Rest of Europe Lysosomal Disease Treatment Market, 2022 - 2028, USD Million
TABLE 185 Rest of Europe Lysosomal Disease Treatment Market by Disease Type, 2018 - 2021, USD Million
TABLE 186 Rest of Europe Lysosomal Disease Treatment Market by Disease Type, 2022 - 2028, USD Million
TABLE 187 Rest of Europe Lysosomal Disease Treatment Market by Type of Therapy, 2018 - 2021, USD Million
TABLE 188 Rest of Europe Lysosomal Disease Treatment Market by Type of Therapy, 2022 - 2028, USD Million
TABLE 189 Rest of Europe Lysosomal Disease Treatment Market by End User, 2018 - 2021, USD Million
TABLE 190 Rest of Europe Lysosomal Disease Treatment Market by End User, 2022 - 2028, USD Million
TABLE 191 Asia Pacific Lysosomal Disease Treatment Market, 2018 - 2021, USD Million
TABLE 192 Asia Pacific Lysosomal Disease Treatment Market, 2022 - 2028, USD Million
TABLE 193 Asia Pacific Lysosomal Disease Treatment Market by Disease Type, 2018 - 2021, USD Million
TABLE 194 Asia Pacific Lysosomal Disease Treatment Market by Disease Type, 2022 - 2028, USD Million
TABLE 195 Asia Pacific Gaucher's Diseases Market by Country, 2018 - 2021, USD Million
TABLE 196 Asia Pacific Gaucher's Diseases Market by Country, 2022 - 2028, USD Million
TABLE 197 Asia Pacific Fabry Diseases Market by Country, 2018 - 2021, USD Million
TABLE 198 Asia Pacific Fabry Diseases Market by Country, 2022 - 2028, USD Million
TABLE 199 Asia Pacific Mucopolysaccharidosis Market by Country, 2018 - 2021, USD Million
TABLE 200 Asia Pacific Mucopolysaccharidosis Market by Country, 2022 - 2028, USD Million
TABLE 201 Asia Pacific Pompe's Syndrome Market by Country, 2018 - 2021, USD Million
TABLE 202 Asia Pacific Pompe's Syndrome Market by Country, 2022 - 2028, USD Million
TABLE 203 Asia Pacific Others Market by Country, 2018 - 2021, USD Million
TABLE 204 Asia Pacific Others Market by Country, 2022 - 2028, USD Million
TABLE 205 Asia Pacific Lysosomal Disease Treatment Market by Type of Therapy, 2018 - 2021, USD Million
TABLE 206 Asia Pacific Lysosomal Disease Treatment Market by Type of Therapy, 2022 - 2028, USD Million
TABLE 207 Asia Pacific Enzyme Replacement Therapy Market by Country, 2018 - 2021, USD Million
TABLE 208 Asia Pacific Enzyme Replacement Therapy Market by Country, 2022 - 2028, USD Million
TABLE 209 Asia Pacific Substrate Reduction Therapy Market by Country, 2018 - 2021, USD Million
TABLE 210 Asia Pacific Substrate Reduction Therapy Market by Country, 2022 - 2028, USD Million
TABLE 211 Asia Pacific Stem Cell Therapy Market by Country, 2018 - 2021, USD Million
TABLE 212 Asia Pacific Stem Cell Therapy Market by Country, 2022 - 2028, USD Million
TABLE 213 Asia Pacific Others Market by Country, 2018 - 2021, USD Million
TABLE 214 Asia Pacific Others Market by Country, 2022 - 2028, USD Million
TABLE 215 Asia Pacific Lysosomal Disease Treatment Market by End User, 2018 - 2021, USD Million
TABLE 216 Asia Pacific Lysosomal Disease Treatment Market by End User, 2022 - 2028, USD Million
TABLE 217 Asia Pacific Hospitals Market by Country, 2018 - 2021, USD Million
TABLE 218 Asia Pacific Hospitals Market by Country, 2022 - 2028, USD Million
TABLE 219 Asia Pacific Clinics Market by Country, 2018 - 2021, USD Million
TABLE 220 Asia Pacific Clinics Market by Country, 2022 - 2028, USD Million
TABLE 221 Asia Pacific Others Market by Country, 2018 - 2021, USD Million
TABLE 222 Asia Pacific Others Market by Country, 2022 - 2028, USD Million
TABLE 223 Asia Pacific Lysosomal Disease Treatment Market by Country, 2018 - 2021, USD Million
TABLE 224 Asia Pacific Lysosomal Disease Treatment Market by Country, 2022 - 2028, USD Million
TABLE 225 China Lysosomal Disease Treatment Market, 2018 - 2021, USD Million
TABLE 226 China Lysosomal Disease Treatment Market, 2022 - 2028, USD Million
TABLE 227 China Lysosomal Disease Treatment Market by Disease Type, 2018 - 2021, USD Million
TABLE 228 China Lysosomal Disease Treatment Market by Disease Type, 2022 - 2028, USD Million
TABLE 229 China Lysosomal Disease Treatment Market by Type of Therapy, 2018 - 2021, USD Million
TABLE 230 China Lysosomal Disease Treatment Market by Type of Therapy, 2022 - 2028, USD Million
TABLE 231 China Lysosomal Disease Treatment Market by End User, 2018 - 2021, USD Million
TABLE 232 China Lysosomal Disease Treatment Market by End User, 2022 - 2028, USD Million
TABLE 233 Japan Lysosomal Disease Treatment Market, 2018 - 2021, USD Million
TABLE 234 Japan Lysosomal Disease Treatment Market, 2022 - 2028, USD Million
TABLE 235 Japan Lysosomal Disease Treatment Market by Disease Type, 2018 - 2021, USD Million
TABLE 236 Japan Lysosomal Disease Treatment Market by Disease Type, 2022 - 2028, USD Million
TABLE 237 Japan Lysosomal Disease Treatment Market by Type of Therapy, 2018 - 2021, USD Million
TABLE 238 Japan Lysosomal Disease Treatment Market by Type of Therapy, 2022 - 2028, USD Million
TABLE 239 Japan Lysosomal Disease Treatment Market by End User, 2018 - 2021, USD Million
TABLE 240 Japan Lysosomal Disease Treatment Market by End User, 2022 - 2028, USD Million
TABLE 241 India Lysosomal Disease Treatment Market, 2018 - 2021, USD Million
TABLE 242 India Lysosomal Disease Treatment Market, 2022 - 2028, USD Million
TABLE 243 India Lysosomal Disease Treatment Market by Disease Type, 2018 - 2021, USD Million
TABLE 244 India Lysosomal Disease Treatment Market by Disease Type, 2022 - 2028, USD Million
TABLE 245 India Lysosomal Disease Treatment Market by Type of Therapy, 2018 - 2021, USD Million
TABLE 246 India Lysosomal Disease Treatment Market by Type of Therapy, 2022 - 2028, USD Million
TABLE 247 India Lysosomal Disease Treatment Market by End User, 2018 - 2021, USD Million
TABLE 248 India Lysosomal Disease Treatment Market by End User, 2022 - 2028, USD Million
TABLE 249 South Korea Lysosomal Disease Treatment Market, 2018 - 2021, USD Million
TABLE 250 South Korea Lysosomal Disease Treatment Market, 2022 - 2028, USD Million
TABLE 251 South Korea Lysosomal Disease Treatment Market by Disease Type, 2018 - 2021, USD Million
TABLE 252 South Korea Lysosomal Disease Treatment Market by Disease Type, 2022 - 2028, USD Million
TABLE 253 South Korea Lysosomal Disease Treatment Market by Type of Therapy, 2018 - 2021, USD Million
TABLE 254 South Korea Lysosomal Disease Treatment Market by Type of Therapy, 2022 - 2028, USD Million
TABLE 255 South Korea Lysosomal Disease Treatment Market by End User, 2018 - 2021, USD Million
TABLE 256 South Korea Lysosomal Disease Treatment Market by End User, 2022 - 2028, USD Million
TABLE 257 Singapore Lysosomal Disease Treatment Market, 2018 - 2021, USD Million
TABLE 258 Singapore Lysosomal Disease Treatment Market, 2022 - 2028, USD Million
TABLE 259 Singapore Lysosomal Disease Treatment Market by Disease Type, 2018 - 2021, USD Million
TABLE 260 Singapore Lysosomal Disease Treatment Market by Disease Type, 2022 - 2028, USD Million
TABLE 261 Singapore Lysosomal Disease Treatment Market by Type of Therapy, 2018 - 2021, USD Million
TABLE 262 Singapore Lysosomal Disease Treatment Market by Type of Therapy, 2022 - 2028, USD Million
TABLE 263 Singapore Lysosomal Disease Treatment Market by End User, 2018 - 2021, USD Million
TABLE 264 Singapore Lysosomal Disease Treatment Market by End User, 2022 - 2028, USD Million
TABLE 265 Malaysia Lysosomal Disease Treatment Market, 2018 - 2021, USD Million
TABLE 266 Malaysia Lysosomal Disease Treatment Market, 2022 - 2028, USD Million
TABLE 267 Malaysia Lysosomal Disease Treatment Market by Disease Type, 2018 - 2021, USD Million
TABLE 268 Malaysia Lysosomal Disease Treatment Market by Disease Type, 2022 - 2028, USD Million
TABLE 269 Malaysia Lysosomal Disease Treatment Market by Type of Therapy, 2018 - 2021, USD Million
TABLE 270 Malaysia Lysosomal Disease Treatment Market by Type of Therapy, 2022 - 2028, USD Million
TABLE 271 Malaysia Lysosomal Disease Treatment Market by End User, 2018 - 2021, USD Million
TABLE 272 Malaysia Lysosomal Disease Treatment Market by End User, 2022 - 2028, USD Million
TABLE 273 Rest of Asia Pacific Lysosomal Disease Treatment Market, 2018 - 2021, USD Million
TABLE 274 Rest of Asia Pacific Lysosomal Disease Treatment Market, 2022 - 2028, USD Million
TABLE 275 Rest of Asia Pacific Lysosomal Disease Treatment Market by Disease Type, 2018 - 2021, USD Million
TABLE 276 Rest of Asia Pacific Lysosomal Disease Treatment Market by Disease Type, 2022 - 2028, USD Million
TABLE 277 Rest of Asia Pacific Lysosomal Disease Treatment Market by Type of Therapy, 2018 - 2021, USD Million
TABLE 278 Rest of Asia Pacific Lysosomal Disease Treatment Market by Type of Therapy, 2022 - 2028, USD Million
TABLE 279 Rest of Asia Pacific Lysosomal Disease Treatment Market by End User, 2018 - 2021, USD Million
TABLE 280 Rest of Asia Pacific Lysosomal Disease Treatment Market by End User, 2022 - 2028, USD Million
TABLE 281 LAMEA Lysosomal Disease Treatment Market, 2018 - 2021, USD Million
TABLE 282 LAMEA Lysosomal Disease Treatment Market, 2022 - 2028, USD Million
TABLE 283 LAMEA Lysosomal Disease Treatment Market by Disease Type, 2018 - 2021, USD Million
TABLE 284 LAMEA Lysosomal Disease Treatment Market by Disease Type, 2022 - 2028, USD Million
TABLE 285 LAMEA Gaucher's Diseases Market by Country, 2018 - 2021, USD Million
TABLE 286 LAMEA Gaucher's Diseases Market by Country, 2022 - 2028, USD Million
TABLE 287 LAMEA Fabry Diseases Market by Country, 2018 - 2021, USD Million
TABLE 288 LAMEA Fabry Diseases Market by Country, 2022 - 2028, USD Million
TABLE 289 LAMEA Mucopolysaccharidosis Market by Country, 2018 - 2021, USD Million
TABLE 290 LAMEA Mucopolysaccharidosis Market by Country, 2022 - 2028, USD Million
TABLE 291 LAMEA Pompe's Syndrome Market by Country, 2018 - 2021, USD Million
TABLE 292 LAMEA Pompe's Syndrome Market by Country, 2022 - 2028, USD Million
TABLE 293 LAMEA Others Market by Country, 2018 - 2021, USD Million
TABLE 294 LAMEA Others Market by Country, 2022 - 2028, USD Million
TABLE 295 LAMEA Lysosomal Disease Treatment Market by Type of Therapy, 2018 - 2021, USD Million
TABLE 296 LAMEA Lysosomal Disease Treatment Market by Type of Therapy, 2022 - 2028, USD Million
TABLE 297 LAMEA Enzyme Replacement Therapy Market by Country, 2018 - 2021, USD Million
TABLE 298 LAMEA Enzyme Replacement Therapy Market by Country, 2022 - 2028, USD Million
TABLE 299 LAMEA Substrate Reduction Therapy Market by Country, 2018 - 2021, USD Million
TABLE 300 LAMEA Substrate Reduction Therapy Market by Country, 2022 - 2028, USD Million
TABLE 301 LAMEA Stem Cell Therapy Market by Country, 2018 - 2021, USD Million
TABLE 302 LAMEA Stem Cell Therapy Market by Country, 2022 - 2028, USD Million
TABLE 303 LAMEA Others Market by Country, 2018 - 2021, USD Million
TABLE 304 LAMEA Others Market by Country, 2022 - 2028, USD Million
TABLE 305 LAMEA Lysosomal Disease Treatment Market by End User, 2018 - 2021, USD Million
TABLE 306 LAMEA Lysosomal Disease Treatment Market by End User, 2022 - 2028, USD Million
TABLE 307 LAMEA Hospitals Market by Country, 2018 - 2021, USD Million
TABLE 308 LAMEA Hospitals Market by Country, 2022 - 2028, USD Million
TABLE 309 LAMEA Clinics Market by Country, 2018 - 2021, USD Million
TABLE 310 LAMEA Clinics Market by Country, 2022 - 2028, USD Million
TABLE 311 LAMEA Others Market by Country, 2018 - 2021, USD Million
TABLE 312 LAMEA Others Market by Country, 2022 - 2028, USD Million
TABLE 313 LAMEA Lysosomal Disease Treatment Market by Country, 2018 - 2021, USD Million
TABLE 314 LAMEA Lysosomal Disease Treatment Market by Country, 2022 - 2028, USD Million
TABLE 315 Brazil Lysosomal Disease Treatment Market, 2018 - 2021, USD Million
TABLE 316 Brazil Lysosomal Disease Treatment Market, 2022 - 2028, USD Million
TABLE 317 Brazil Lysosomal Disease Treatment Market by Disease Type, 2018 - 2021, USD Million
TABLE 318 Brazil Lysosomal Disease Treatment Market by Disease Type, 2022 - 2028, USD Million
TABLE 319 Brazil Lysosomal Disease Treatment Market by Type of Therapy, 2018 - 2021, USD Million
TABLE 320 Brazil Lysosomal Disease Treatment Market by Type of Therapy, 2022 - 2028, USD Million
TABLE 321 Brazil Lysosomal Disease Treatment Market by End User, 2018 - 2021, USD Million
TABLE 322 Brazil Lysosomal Disease Treatment Market by End User, 2022 - 2028, USD Million
TABLE 323 Argentina Lysosomal Disease Treatment Market, 2018 - 2021, USD Million
TABLE 324 Argentina Lysosomal Disease Treatment Market, 2022 - 2028, USD Million
TABLE 325 Argentina Lysosomal Disease Treatment Market by Disease Type, 2018 - 2021, USD Million
TABLE 326 Argentina Lysosomal Disease Treatment Market by Disease Type, 2022 - 2028, USD Million
TABLE 327 Argentina Lysosomal Disease Treatment Market by Type of Therapy, 2018 - 2021, USD Million
TABLE 328 Argentina Lysosomal Disease Treatment Market by Type of Therapy, 2022 - 2028, USD Million
TABLE 329 Argentina Lysosomal Disease Treatment Market by End User, 2018 - 2021, USD Million
TABLE 330 Argentina Lysosomal Disease Treatment Market by End User, 2022 - 2028, USD Million
TABLE 331 UAE Lysosomal Disease Treatment Market, 2018 - 2021, USD Million
TABLE 332 UAE Lysosomal Disease Treatment Market, 2022 - 2028, USD Million
TABLE 333 UAE Lysosomal Disease Treatment Market by Disease Type, 2018 - 2021, USD Million
TABLE 334 UAE Lysosomal Disease Treatment Market by Disease Type, 2022 - 2028, USD Million
TABLE 335 UAE Lysosomal Disease Treatment Market by Type of Therapy, 2018 - 2021, USD Million
TABLE 336 UAE Lysosomal Disease Treatment Market by Type of Therapy, 2022 - 2028, USD Million
TABLE 337 UAE Lysosomal Disease Treatment Market by End User, 2018 - 2021, USD Million
TABLE 338 UAE Lysosomal Disease Treatment Market by End User, 2022 - 2028, USD Million
TABLE 339 Saudi Arabia Lysosomal Disease Treatment Market, 2018 - 2021, USD Million
TABLE 340 Saudi Arabia Lysosomal Disease Treatment Market, 2022 - 2028, USD Million
TABLE 341 Saudi Arabia Lysosomal Disease Treatment Market by Disease Type, 2018 - 2021, USD Million
TABLE 342 Saudi Arabia Lysosomal Disease Treatment Market by Disease Type, 2022 - 2028, USD Million
TABLE 343 Saudi Arabia Lysosomal Disease Treatment Market by Type of Therapy, 2018 - 2021, USD Million
TABLE 344 Saudi Arabia Lysosomal Disease Treatment Market by Type of Therapy, 2022 - 2028, USD Million
TABLE 345 Saudi Arabia Lysosomal Disease Treatment Market by End User, 2018 - 2021, USD Million
TABLE 346 Saudi Arabia Lysosomal Disease Treatment Market by End User, 2022 - 2028, USD Million

TABLE 347 South Africa Lysosomal Disease Treatment Market, 2018 - 2021, USD Million
TABLE 348 South Africa Lysosomal Disease Treatment Market, 2022 - 2028, USD Million
TABLE 349 South Africa Lysosomal Disease Treatment Market by Disease Type, 2018 - 2021, USD Million
TABLE 350 South Africa Lysosomal Disease Treatment Market by Disease Type, 2022 - 2028, USD Million
TABLE 351 South Africa Lysosomal Disease Treatment Market by Type of Therapy, 2018 - 2021, USD Million
TABLE 352 South Africa Lysosomal Disease Treatment Market by Type of Therapy, 2022 - 2028, USD Million
TABLE 353 South Africa Lysosomal Disease Treatment Market by End User, 2018 - 2021, USD Million
TABLE 354 South Africa Lysosomal Disease Treatment Market by End User, 2022 - 2028, USD Million
TABLE 355 Nigeria Lysosomal Disease Treatment Market, 2018 - 2021, USD Million
TABLE 356 Nigeria Lysosomal Disease Treatment Market, 2022 - 2028, USD Million
TABLE 357 Nigeria Lysosomal Disease Treatment Market by Disease Type, 2018 - 2021, USD Million
TABLE 358 Nigeria Lysosomal Disease Treatment Market by Disease Type, 2022 - 2028, USD Million
TABLE 359 Nigeria Lysosomal Disease Treatment Market by Type of Therapy, 2018 - 2021, USD Million
TABLE 360 Nigeria Lysosomal Disease Treatment Market by Type of Therapy, 2022 - 2028, USD Million
TABLE 361 Nigeria Lysosomal Disease Treatment Market by End User, 2018 - 2021, USD Million
TABLE 362 Nigeria Lysosomal Disease Treatment Market by End User, 2022 - 2028, USD Million
TABLE 363 Rest of LAMEA Lysosomal Disease Treatment Market, 2018 - 2021, USD Million
TABLE 364 Rest of LAMEA Lysosomal Disease Treatment Market, 2022 - 2028, USD Million
TABLE 365 Rest of LAMEA Lysosomal Disease Treatment Market by Disease Type, 2018 - 2021, USD Million
TABLE 366 Rest of LAMEA Lysosomal Disease Treatment Market by Disease Type, 2022 - 2028, USD Million
TABLE 367 Rest of LAMEA Lysosomal Disease Treatment Market by Type of Therapy, 2018 - 2021, USD Million
TABLE 368 Rest of LAMEA Lysosomal Disease Treatment Market by Type of Therapy, 2022 - 2028, USD Million
TABLE 369 Rest of LAMEA Lysosomal Disease Treatment Market by End User, 2018 - 2021, USD Million
TABLE 370 Rest of LAMEA Lysosomal Disease Treatment Market by End User, 2022 - 2028, USD Million
TABLE 371 KEY INFORMATION - MERCK & CO., INC.
TABLE 372 Key information -Johnson & Johnson
TABLE 373 Key Information - Eli Lilly And Company
TABLE 374 Key Information - Pfizer, Inc.
TABLE 375 Key Information - Takeda Pharmaceutical Company Limited
TABLE 376 Key Information - Sanofi S.A.
TABLE 377 Key Information - Novartis AG
TABLE 378 KEY INFORMATION - ASTRAZENECA PLC
TABLE 379 Key Information - BioMarin Pharmaceutical Inc.
TABLE 380 Key Information - Sigilon Therapeutics, Inc.

List of Figures

FIG 1 Methodology for the research
FIG 2 Global Lysosomal Disease Treatment Market Share by Disease Type, 2021
FIG 3 Global Lysosomal Disease Treatment Market Share by Disease Type, 2028
FIG 4 Global Lysosomal Disease Treatment Market by Disease Type, 2018 - 2028, USD Million
FIG 5 Global Lysosomal Disease Treatment Market Share by Type of Therapy, 2021
FIG 6 Global Lysosomal Disease Treatment Market Share by Type of Therapy, 2028
FIG 7 Global Lysosomal Disease Treatment Market by Type of Therapy, 2018 - 2028, USD Million
FIG 8 Global Lysosomal Disease Treatment Market Share by End User, 2021
FIG 9 Global Lysosomal Disease Treatment Market Share by End User, 2028
FIG 10 Global Lysosomal Disease Treatment Market by End User, 2018 - 2028, USD Million
FIG 11 Global Lysosomal Disease Treatment Market Share by Region, 2021
FIG 12 Global Lysosomal Disease Treatment Market Share by Region, 2028
FIG 13 Global Lysosomal Disease Treatment Market by Region, 2018 - 2028, USD Million

The Global Lysosomal Disease Treatment Market size is expected to reach $11 billion by 2028, rising at a market growth of 6.3% CAGR during the forecast period.

Lysosomal diseases (LSDs) are a complex group of metabolic disorders that are often inherited in an autosomal recessive manner. There are currently 45 known diseases. They are caused by malfunctions in various lysosomal processes, most often by abnormalities in genes that produce catabolic enzymes responsible for the breakdown of macromolecules. As the faulty enzyme accumulates substrate, cell malfunction and clinical symptoms escalate.

Other types of lysosomal dysfunction that can lead to lysosomal storage include defects in post-translational processing of lysosomal enzymes, errors in enzyme trafficking or targeting, and dysfunction of non-enzymatic transmembrane and solubilize.

Lysosomal hydrolase mutations, which are implicated in the breakdown of cellular macromolecules, are the primary cause of LSDs, accounting for more than two-thirds of cases. As a result, there are many different types of lipids, glycogen, mucopolysaccharides, and glycoproteins among the storage products in LSDs that are biochemical in origin. The LSDs are all inherited as autosomal recessive characteristics, except the X-linked Fabry, Danon, and Hunter diseases.

The LSDs can affect the majority of organs, either alone or as part of a multisystem illness, and are clinically very heterogeneous. Even though lysosomal enzymes are housekeeping genes and expressed in the majority of cells, the tissues on which they act are distributed much less uniformly, and this determines which tissues in any individual are affected.

COVID-19 Impact Analysis

The COVID-19 public health crisis has affected almost every industry. The COVID-19 outbreak has caused a significant decrease in demand for the lysosomal disease treatment size of the market across several sectors, especially the health and pharmaceutical sector, as coronavirus crises sweep the globe and force healthcare providers to devote a large percentage of their funds to fighting COVID-19. The risk of infection was the primary factor contributing to the delays in treatment that patients with lysosomal storage disorder encountered in hospitals. The COVID-19 outbreak harms the market's value in 2022 and beyond because it will delay the development of the worldwide market for lysosomal disease treatments.

Market Growth Factor

Incidence of Lysosomal Disorders Are Rising

The primary driving forces in the enzyme replacement therapy market are the expanding research and development for lysosomal disease diagnosis and drug development for treatment. The increasing incidence of lysosomal disease will be a key factor contributing to the acceleration of the market's growth rate. According to a report published by the National Center for Biotechnology Information, the prevalence of Fabry disease in communities of white, male individuals ranged from 1:17,000 to 1:117,000 in January 2020. Atypical presentations were associated with around 1:6000-1:40,000 females and 1:1000-1:3000 males, whereas 1:22,000-1:40,000 males had the classic Fabry disease mutations.

Financial Incentives for Developing Orphan Drugs to Recoup R&D Expenses

The increases in healthcare spending, which helps to improve its infrastructure, is a crucial element affecting the market's growth rate for therapies for lysosomal diseases. The market dynamics will be further impacted by various government organizations' efforts to strengthen the healthcare infrastructure by boosting funding. Additionally, the market for lysosomal disease therapies will grow as a result of the rising acceptance rate of early diagnosis and the increasing number of government programs to raise awareness. Along with this, expanding government benevolent programs and an increase in disposable money would accelerate market expansion.

Market Restraining Factor

The Treatment of Stem Cells Is Fraught with Issues

Many of the issues that can arise soon after the transplant are caused by the bone marrow being destroyed just before it by drugs or radiation. Some may be unintended consequences of the conditioning procedures themselves. The patient can get support from the transplant team to manage side effects. Most can be addressed to make the patient feel better, and some can be prevented. This is not a comprehensive list, so please inform the physician or the transplant team of any issues or adjustments that experience.

Disease Type Outlook

Based on the Disease Type, the Lysosomal Disease Treatment Market is segmented into Gaucher's Diseases, Fabry Diseases, Pompe's Syndrome, Mucopolysaccharidosis, and Others. The Gaucher's disease segment acquired the highest revenue share in the lysosomal disease treatment market in 2021. It is due to the rising prevalence of Gaucher's disease is the main market growth driver. Additionally, this segment's growth is fueled by potent approved medications and new treatments that are under development.

Type of Therapy Outlook

On the basis of Type of Therapy, the Lysosomal Disease Treatment Market is divided into Enzyme Replacement Therapy, Stem Cell Therapy, Substrate Reduction Therapy, and Others. The stem cell therapy segment registered a substantial revenue share in the lysosomal disease treatment market in 2021. LSDs are a very appealing target for stem cell therapy due to the capacity to perform cross-correction through secretion-reuptake of lysosomal hydrolases, and allogeneic transplantation of bone marrow was the first specific therapeutic method to be applied to LSDs.

End User Outlook

By End-user, the Lysosomal Disease Treatment Market is bifurcated into Hospitals, Clinics, and Others. The hospital segment garnered the highest revenue share in the lysosomal disease treatment market in 2021. due to an increase in people seeking hospital care for lysosomal illnesses. In response to the rising demand for clinical practices to be streamlined cost-effectively, hospitals are using these technologies. A hospital is a facility with skilled medical staff, administrative staff, and medical equipment where people can receive medical care.

Regional Outlook

Region-wise, the Lysosomal Disease Treatment Market is analyzed across North America, Europe, Asia Pacific, and LAMEA. The North America segment acquired the largest revenue share in the lysosomal disease treatment market in 2021. Due to the lysosomal disease's high prevalence in North America. The development of new medical therapies, advancements in diagnostic technology, and growing public awareness of lysosomal disorders is fueling this market's expansion. Countries have used a variety of strategies that matched their particular needs to address this particular issue of high costs.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Merck & Co., Inc., Johnson & Johnson (Janssen Global Services, LLC), Eli Lilly And Company, Pfizer, Inc., Takeda Pharmaceutical Company Limited, Sanofi S.A., Novartis AG, AstraZeneca PLC (Alexion Pharmaceuticals, Inc.), BioMarin Pharmaceutical Inc. and Sigilon Therapeutics, Inc.

Scope of the Study

Market Segments covered in the Report:

By Disease Type

Gaucher's Diseases
Fabry Diseases
Mucopolysaccharidosis
Pompe's Syndrome
Others

By Type of Therapy

Enzyme Replacement Therapy
Substrate Reduction Therapy
Stem Cell Therapy
Others

By End User

Hospitals
Clinics
Others

By Geography

North America
- US
- Canada
- Mexico
- Rest of North America
Europe
- Germany
- UK
- France
- Russia
- Spain
- Italy
- Rest of Europe
Asia Pacific
- China
- Japan
- India
- South Korea
- Singapore
- Malaysia
- Rest of Asia Pacific
LAMEA
- Brazil
- Argentina
- UAE
- Saudi Arabia
- South Africa
- Nigeria
- Rest of LAMEA

Companies Profiled

Merck & Co., Inc.
Johnson & Johnson (Janssen Global Services, LLC)
Eli Lilly And Company
Pfizer, Inc.
Takeda Pharmaceutical Company Limited
Sanofi S.A.
Novartis AG
AstraZeneca PLC (Alexion Pharmaceuticals, Inc.)
BioMarin Pharmaceutical Inc.
Sigilon Therapeutics, Inc.

Unique Offerings from KBV Research

Exhaustive coverage
Highest number of market tables and figures
Subscription based model available
Guaranteed best price
Assured post sales research support with 10% customization free

Chapter 1. Market Scope & Methodology

1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
- 1.4.1 Global Lysosomal Disease Treatment Market, by Disease Type
- 1.4.2 Global Lysosomal Disease Treatment Market, by Type of Therapy
- 1.4.3 Global Lysosomal Disease Treatment Market, by End User
- 1.4.4 Global Lysosomal Disease Treatment Market, by Geography
1.5 Methodology for the research

Chapter 2. Market Overview

2.1 Introduction
- 2.1.1 Overview
  - 2.1.1.1 Market composition & scenarios
2.2 Key Factors Impacting the Market
- 2.2.1 Market Drivers
- 2.2.2 Market Restraints

Chapter 3. Global Lysosomal Disease Treatment Market by Disease Type

3.1 Global Gaucher's Diseases Market by Region
3.2 Global Fabry Diseases Market by Region
3.3 Global Mucopolysaccharidosis Market by Region
3.4 Global Pompe's Syndrome Market by Region
3.5 Global Others Market by Region

Chapter 4. Global Lysosomal Disease Treatment Market by Type of Therapy

4.1 Global Enzyme Replacement Therapy Market by Region
4.2 Global Substrate Reduction Therapy Market by Region
4.3 Global Stem Cell Therapy Market by Region
4.4 Global Others Market by Region

Chapter 5. Global Lysosomal Disease Treatment Market by End User

5.1 Global Hospitals Market by Region
5.2 Global Clinics Market by Region
5.3 Global Others Market by Region

Chapter 6. Global Lysosomal Disease Treatment Market by Region

6.1 North America Lysosomal Disease Treatment Market
- 6.1.1 North America Lysosomal Disease Treatment Market by Disease Type
  - 6.1.1.1 North America Gaucher's Diseases Market by Country
  - 6.1.1.2 North America Fabry Diseases Market by Country
  - 6.1.1.3 North America Mucopolysaccharidosis Market by Country
  - 6.1.1.4 North America Pompe's Syndrome Market by Country
  - 6.1.1.5 North America Others Market by Country
- 6.1.2 North America Lysosomal Disease Treatment Market by Type of Therapy
  - 6.1.2.1 North America Enzyme Replacement Therapy Market by Country
  - 6.1.2.2 North America Substrate Reduction Therapy Market by Country
  - 6.1.2.3 North America Stem Cell Therapy Market by Country
  - 6.1.2.4 North America Others Market by Country
- 6.1.3 North America Lysosomal Disease Treatment Market by End User
  - 6.1.3.1 North America Hospitals Market by Country
  - 6.1.3.2 North America Clinics Market by Country
  - 6.1.3.3 North America Others Market by Country
- 6.1.4 North America Lysosomal Disease Treatment Market by Country
  - 6.1.4.1 US Lysosomal Disease Treatment Market
    - 6.1.4.1.1 US Lysosomal Disease Treatment Market by Disease Type
    - 6.1.4.1.2 US Lysosomal Disease Treatment Market by Type of Therapy
    - 6.1.4.1.3 US Lysosomal Disease Treatment Market by End User
  - 6.1.4.2 Canada Lysosomal Disease Treatment Market
    - 6.1.4.2.1 Canada Lysosomal Disease Treatment Market by Disease Type
    - 6.1.4.2.2 Canada Lysosomal Disease Treatment Market by Type of Therapy
    - 6.1.4.2.3 Canada Lysosomal Disease Treatment Market by End User
  - 6.1.4.3 Mexico Lysosomal Disease Treatment Market
    - 6.1.4.3.1 Mexico Lysosomal Disease Treatment Market by Disease Type
    - 6.1.4.3.2 Mexico Lysosomal Disease Treatment Market by Type of Therapy
    - 6.1.4.3.3 Mexico Lysosomal Disease Treatment Market by End User
  - 6.1.4.4 Rest of North America Lysosomal Disease Treatment Market
    - 6.1.4.4.1 Rest of North America Lysosomal Disease Treatment Market by Disease Type
    - 6.1.4.4.2 Rest of North America Lysosomal Disease Treatment Market by Type of Therapy
    - 6.1.4.4.3 Rest of North America Lysosomal Disease Treatment Market by End User
6.2 Europe Lysosomal Disease Treatment Market
- 6.2.1 Europe Lysosomal Disease Treatment Market by Disease Type
  - 6.2.1.1 Europe Gaucher's Diseases Market by Country
  - 6.2.1.2 Europe Fabry Diseases Market by Country
  - 6.2.1.3 Europe Mucopolysaccharidosis Market by Country
  - 6.2.1.4 Europe Pompe's Syndrome Market by Country
  - 6.2.1.5 Europe Others Market by Country
- 6.2.2 Europe Lysosomal Disease Treatment Market by Type of Therapy
  - 6.2.2.1 Europe Enzyme Replacement Therapy Market by Country
  - 6.2.2.2 Europe Substrate Reduction Therapy Market by Country
  - 6.2.2.3 Europe Stem Cell Therapy Market by Country
  - 6.2.2.4 Europe Others Market by Country
- 6.2.3 Europe Lysosomal Disease Treatment Market by End User
  - 6.2.3.1 Europe Hospitals Market by Country
  - 6.2.3.2 Europe Clinics Market by Country
  - 6.2.3.3 Europe Others Market by Country
- 6.2.4 Europe Lysosomal Disease Treatment Market by Country
  - 6.2.4.1 Germany Lysosomal Disease Treatment Market
    - 6.2.4.1.1 Germany Lysosomal Disease Treatment Market by Disease Type
    - 6.2.4.1.2 Germany Lysosomal Disease Treatment Market by Type of Therapy
    - 6.2.4.1.3 Germany Lysosomal Disease Treatment Market by End User
  - 6.2.4.2 UK Lysosomal Disease Treatment Market
    - 6.2.4.2.1 UK Lysosomal Disease Treatment Market by Disease Type
    - 6.2.4.2.2 UK Lysosomal Disease Treatment Market by Type of Therapy
    - 6.2.4.2.3 UK Lysosomal Disease Treatment Market by End User
  - 6.2.4.3 France Lysosomal Disease Treatment Market
    - 6.2.4.3.1 France Lysosomal Disease Treatment Market by Disease Type
    - 6.2.4.3.2 France Lysosomal Disease Treatment Market by Type of Therapy
    - 6.2.4.3.3 France Lysosomal Disease Treatment Market by End User
  - 6.2.4.4 Russia Lysosomal Disease Treatment Market
    - 6.2.4.4.1 Russia Lysosomal Disease Treatment Market by Disease Type
    - 6.2.4.4.2 Russia Lysosomal Disease Treatment Market by Type of Therapy
    - 6.2.4.4.3 Russia Lysosomal Disease Treatment Market by End User
  - 6.2.4.5 Spain Lysosomal Disease Treatment Market
    - 6.2.4.5.1 Spain Lysosomal Disease Treatment Market by Disease Type
    - 6.2.4.5.2 Spain Lysosomal Disease Treatment Market by Type of Therapy
    - 6.2.4.5.3 Spain Lysosomal Disease Treatment Market by End User
  - 6.2.4.6 Italy Lysosomal Disease Treatment Market
    - 6.2.4.6.1 Italy Lysosomal Disease Treatment Market by Disease Type
    - 6.2.4.6.2 Italy Lysosomal Disease Treatment Market by Type of Therapy
    - 6.2.4.6.3 Italy Lysosomal Disease Treatment Market by End User
  - 6.2.4.7 Rest of Europe Lysosomal Disease Treatment Market
    - 6.2.4.7.1 Rest of Europe Lysosomal Disease Treatment Market by Disease Type
    - 6.2.4.7.2 Rest of Europe Lysosomal Disease Treatment Market by Type of Therapy
    - 6.2.4.7.3 Rest of Europe Lysosomal Disease Treatment Market by End User
6.3 Asia Pacific Lysosomal Disease Treatment Market
- 6.3.1 Asia Pacific Lysosomal Disease Treatment Market by Disease Type
  - 6.3.1.1 Asia Pacific Gaucher's Diseases Market by Country
  - 6.3.1.2 Asia Pacific Fabry Diseases Market by Country
  - 6.3.1.3 Asia Pacific Mucopolysaccharidosis Market by Country
  - 6.3.1.4 Asia Pacific Pompe's Syndrome Market by Country
  - 6.3.1.5 Asia Pacific Others Market by Country
- 6.3.2 Asia Pacific Lysosomal Disease Treatment Market by Type of Therapy
  - 6.3.2.1 Asia Pacific Enzyme Replacement Therapy Market by Country
  - 6.3.2.2 Asia Pacific Substrate Reduction Therapy Market by Country
  - 6.3.2.3 Asia Pacific Stem Cell Therapy Market by Country
  - 6.3.2.4 Asia Pacific Others Market by Country
- 6.3.3 Asia Pacific Lysosomal Disease Treatment Market by End User
  - 6.3.3.1 Asia Pacific Hospitals Market by Country
  - 6.3.3.2 Asia Pacific Clinics Market by Country
  - 6.3.3.3 Asia Pacific Others Market by Country
- 6.3.4 Asia Pacific Lysosomal Disease Treatment Market by Country
  - 6.3.4.1 China Lysosomal Disease Treatment Market
    - 6.3.4.1.1 China Lysosomal Disease Treatment Market by Disease Type
    - 6.3.4.1.2 China Lysosomal Disease Treatment Market by Type of Therapy
    - 6.3.4.1.3 China Lysosomal Disease Treatment Market by End User
  - 6.3.4.2 Japan Lysosomal Disease Treatment Market
    - 6.3.4.2.1 Japan Lysosomal Disease Treatment Market by Disease Type
    - 6.3.4.2.2 Japan Lysosomal Disease Treatment Market by Type of Therapy
    - 6.3.4.2.3 Japan Lysosomal Disease Treatment Market by End User
  - 6.3.4.3 India Lysosomal Disease Treatment Market
    - 6.3.4.3.1 India Lysosomal Disease Treatment Market by Disease Type
    - 6.3.4.3.2 India Lysosomal Disease Treatment Market by Type of Therapy
    - 6.3.4.3.3 India Lysosomal Disease Treatment Market by End User
  - 6.3.4.4 South Korea Lysosomal Disease Treatment Market
    - 6.3.4.4.1 South Korea Lysosomal Disease Treatment Market by Disease Type
    - 6.3.4.4.2 South Korea Lysosomal Disease Treatment Market by Type of Therapy
    - 6.3.4.4.3 South Korea Lysosomal Disease Treatment Market by End User
  - 6.3.4.5 Singapore Lysosomal Disease Treatment Market
    - 6.3.4.5.1 Singapore Lysosomal Disease Treatment Market by Disease Type
    - 6.3.4.5.2 Singapore Lysosomal Disease Treatment Market by Type of Therapy
    - 6.3.4.5.3 Singapore Lysosomal Disease Treatment Market by End User
  - 6.3.4.6 Malaysia Lysosomal Disease Treatment Market
    - 6.3.4.6.1 Malaysia Lysosomal Disease Treatment Market by Disease Type
    - 6.3.4.6.2 Malaysia Lysosomal Disease Treatment Market by Type of Therapy
    - 6.3.4.6.3 Malaysia Lysosomal Disease Treatment Market by End User
  - 6.3.4.7 Rest of Asia Pacific Lysosomal Disease Treatment Market
    - 6.3.4.7.1 Rest of Asia Pacific Lysosomal Disease Treatment Market by Disease Type
    - 6.3.4.7.2 Rest of Asia Pacific Lysosomal Disease Treatment Market by Type of Therapy
    - 6.3.4.7.3 Rest of Asia Pacific Lysosomal Disease Treatment Market by End User
6.4 LAMEA Lysosomal Disease Treatment Market
- 6.4.1 LAMEA Lysosomal Disease Treatment Market by Disease Type
  - 6.4.1.1 LAMEA Gaucher's Diseases Market by Country
  - 6.4.1.2 LAMEA Fabry Diseases Market by Country
  - 6.4.1.3 LAMEA Mucopolysaccharidosis Market by Country
  - 6.4.1.4 LAMEA Pompe's Syndrome Market by Country
  - 6.4.1.5 LAMEA Others Market by Country
- 6.4.2 LAMEA Lysosomal Disease Treatment Market by Type of Therapy
  - 6.4.2.1 LAMEA Enzyme Replacement Therapy Market by Country
  - 6.4.2.2 LAMEA Substrate Reduction Therapy Market by Country
  - 6.4.2.3 LAMEA Stem Cell Therapy Market by Country
  - 6.4.2.4 LAMEA Others Market by Country
- 6.4.3 LAMEA Lysosomal Disease Treatment Market by End User
  - 6.4.3.1 LAMEA Hospitals Market by Country
  - 6.4.3.2 LAMEA Clinics Market by Country
  - 6.4.3.3 LAMEA Others Market by Country
- 6.4.4 LAMEA Lysosomal Disease Treatment Market by Country
  - 6.4.4.1 Brazil Lysosomal Disease Treatment Market
    - 6.4.4.1.1 Brazil Lysosomal Disease Treatment Market by Disease Type
    - 6.4.4.1.2 Brazil Lysosomal Disease Treatment Market by Type of Therapy
    - 6.4.4.1.3 Brazil Lysosomal Disease Treatment Market by End User
  - 6.4.4.2 Argentina Lysosomal Disease Treatment Market
    - 6.4.4.2.1 Argentina Lysosomal Disease Treatment Market by Disease Type
    - 6.4.4.2.2 Argentina Lysosomal Disease Treatment Market by Type of Therapy
    - 6.4.4.2.3 Argentina Lysosomal Disease Treatment Market by End User
  - 6.4.4.3 UAE Lysosomal Disease Treatment Market
    - 6.4.4.3.1 UAE Lysosomal Disease Treatment Market by Disease Type
    - 6.4.4.3.2 UAE Lysosomal Disease Treatment Market by Type of Therapy
    - 6.4.4.3.3 UAE Lysosomal Disease Treatment Market by End User
  - 6.4.4.4 Saudi Arabia Lysosomal Disease Treatment Market
    - 6.4.4.4.1 Saudi Arabia Lysosomal Disease Treatment Market by Disease Type
    - 6.4.4.4.2 Saudi Arabia Lysosomal Disease Treatment Market by Type of Therapy
    - 6.4.4.4.3 Saudi Arabia Lysosomal Disease Treatment Market by End User
  - 6.4.4.5 South Africa Lysosomal Disease Treatment Market
    - 6.4.4.5.1 South Africa Lysosomal Disease Treatment Market by Disease Type
    - 6.4.4.5.2 South Africa Lysosomal Disease Treatment Market by Type of Therapy
    - 6.4.4.5.3 South Africa Lysosomal Disease Treatment Market by End User
  - 6.4.4.6 Nigeria Lysosomal Disease Treatment Market
    - 6.4.4.6.1 Nigeria Lysosomal Disease Treatment Market by Disease Type
    - 6.4.4.6.2 Nigeria Lysosomal Disease Treatment Market by Type of Therapy
    - 6.4.4.6.3 Nigeria Lysosomal Disease Treatment Market by End User
  - 6.4.4.7 Rest of LAMEA Lysosomal Disease Treatment Market
    - 6.4.4.7.1 Rest of LAMEA Lysosomal Disease Treatment Market by Disease Type
    - 6.4.4.7.2 Rest of LAMEA Lysosomal Disease Treatment Market by Type of Therapy
    - 6.4.4.7.3 Rest of LAMEA Lysosomal Disease Treatment Market by End User

Chapter 7. Company Profiles

7.1 Merck & Co., Inc.
- 7.1.1 Company Overview
- 7.1.2 Financial Analysis
- 7.1.3 Segmental and Regional Analysis
- 7.1.4 Research & Development Expenses
7.2 Johnson & Johnson (Janssen Global Services, LLC)
- 7.2.1 Company Overview
- 7.2.2 Financial Analysis
- 7.2.3 Segmental &Regional Analysis
- 7.2.4 Research & Development Expenses
7.3 Eli Lilly And Company
- 7.3.1 Company Overview
- 7.3.2 Financial Analysis
- 7.3.3 Regional Analysis
- 7.3.4 Research & Development Expenses
- 7.3.5 Recent strategies and developments:
  - 7.3.5.1 Acquisition and Mergers:
7.4 Pfizer, Inc.
- 7.4.1 Company Overview
- 7.4.2 Financial Analysis
- 7.4.3 Regional & Segmental Analysis
- 7.4.4 Research & Development Expense
- 7.4.5 Recent strategies and developments:
  - 7.4.5.1 Partnerships, Collaborations, and Agreements:
7.5 Takeda Pharmaceutical Company Limited
- 7.5.1 Company Overview
- 7.5.2 Financial Analysis
- 7.5.3 Regional Analysis
- 7.5.4 Research & Development Expense
7.6 Sanofi S.A.
- 7.6.1 Company Overview
- 7.6.2 Financial Analysis
- 7.6.3 Segmental and Regional Analysis
- 7.6.4 Research & Development Expense
- 7.6.5 Recent strategies and developments:
  - 7.6.5.1 Approvals and Trials:
7.7 Novartis AG
- 7.7.1 Company Overview
- 7.7.2 Financial Analysis
- 7.7.3 Segmental and Regional Analysis
- 7.7.4 Research & Development Expense
7.8 AstraZeneca PLC (Alexion Pharmaceuticals, Inc.)
- 7.8.1 Company Overview
- 7.8.2 Financial Analysis
- 7.8.3 Regional Analysis
- 7.8.4 Research & Development Expenses
7.9 BioMarin Pharmaceutical Inc.
- 7.9.1 Company Overview
- 7.9.2 Financial Analysis
- 7.9.3 Regional Analysis
- 7.9.4 Research & Development Expenses
- 7.9.5 Recent strategies and developments:
  - 7.9.5.1 Approvals and Trials:
7.10. Sigilon Therapeutics, Inc.
- 7.10.1 Company Overview
- 7.10.2 Financial Analysis
- 7.10.3 Research & Development Expenses

ライソゾーム病治療の世界市場規模、シェア、産業動向分析レポート：疾患タイプ別、治療タイプ別、エンドユーザー別、地域別展望と予測、2022年～2028年

Global Lysosomal Disease Treatment Market Size, Share & Industry Trends Analysis Report By Disease Type, By Type of Therapy By End User, By Regional Outlook and Forecast, 2022 - 2028

目次

第1章市場の範囲と調査手法

第2章市場概要

第3章ライソゾーム病治療の世界市場：疾患タイプ別

第4章ライソゾーム病治療の世界市場：治療法タイプ別

第5章ライソゾーム病治療の世界市場：エンドユーザー別

第6章ライソゾーム病治療薬の世界市場：地域別

第7章企業プロファイル

LIST OF TABLES

Scope of the Study

Table of Contents

Chapter 1. Market Scope & Methodology

Chapter 2. Market Overview

Chapter 3. Global Lysosomal Disease Treatment Market by Disease Type

Chapter 4. Global Lysosomal Disease Treatment Market by Type of Therapy

Chapter 5. Global Lysosomal Disease Treatment Market by End User

Chapter 6. Global Lysosomal Disease Treatment Market by Region

Chapter 7. Company Profiles

ライソゾーム病治療の世界市場規模、シェア、産業動向分析レポート：疾患タイプ別、治療タイプ別、エンドユーザー別、地域別展望と予測、2022年～2028年

Global Lysosomal Disease Treatment Market Size, Share & Industry Trends Analysis Report By Disease Type, By Type of Therapy By End User, By Regional Outlook and Forecast, 2022 - 2028

目次

第1章 市場の範囲と調査手法

第2章 市場概要

第3章 ライソゾーム病治療の世界市場：疾患タイプ別

第4章 ライソゾーム病治療の世界市場：治療法タイプ別

第5章 ライソゾーム病治療の世界市場：エンドユーザー別

第6章 ライソゾーム病治療薬の世界市場：地域別

第7章 企業プロファイル

LIST OF TABLES

Scope of the Study

Table of Contents

Chapter 1. Market Scope & Methodology

Chapter 2. Market Overview

Chapter 3. Global Lysosomal Disease Treatment Market by Disease Type

Chapter 4. Global Lysosomal Disease Treatment Market by Type of Therapy

Chapter 5. Global Lysosomal Disease Treatment Market by End User

Chapter 6. Global Lysosomal Disease Treatment Market by Region

Chapter 7. Company Profiles

第1章市場の範囲と調査手法

第2章市場概要

第3章ライソゾーム病治療の世界市場：疾患タイプ別

第4章ライソゾーム病治療の世界市場：治療法タイプ別

第5章ライソゾーム病治療の世界市場：エンドユーザー別

第6章ライソゾーム病治療薬の世界市場：地域別

第7章企業プロファイル